NDC 65219-204
Lacosamide
Lacosamide
Lacosamide is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Lacosamide.
| Product ID | 65219-204_4aa7ce0c-5a30-4a80-8b8a-ce83bb126c5d |
| NDC | 65219-204 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lacosamide |
| Generic Name | Lacosamide |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-07-25 |
| Marketing Category | ANDA / |
| Application Number | ANDA214677 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | LACOSAMIDE |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| DEA Schedule | CV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |